Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-3.53%)
Close on Nov 12, 2026Market cap $5.67MP/E –Yield –
Tempest Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Tempest Therapeutics's profit margin for the twelve months ending Sep 30, 2018 was -19991.2%. For fiscal 2017 it was -28670.5%, against -12597.2% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | -28670.5% | −16073.3 |
| FY2016 | Dec 31, 2016 | -12597.2% | +13835.6 |
| FY2015 | Dec 31, 2015 | -26432.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2018 | Sep 30, 2018 | -13701.8% | +3025.0 |
| Q2 FY2018 | Jun 30, 2018 | -5982.7% | +15667.3 |
| Q1 FY2018 | Mar 31, 2018 | -6359.7% | +17283.2 |
| Q4 FY2017 | Dec 31, 2017 | -46297.8% | −27584.6 |
| Q3 FY2017 | Sep 30, 2017 | -16726.8% | −6934.4 |
| Q2 FY2017 | Jun 30, 2017 | -21650.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -23642.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -18713.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -9792.4% | – |
See a number that looks wrong?